Inhibitor Therapeutics, Inc.
INTI· OTC
INTIInhibitor Therapeutics, Inc.
Filed Nov 14, 2013 · 10-Q · 45 days after period end · 0001193125-13-442198
| Metric | Q3 2013 | Q3 2012 |
|---|---|---|
| Net Income | -$1.29M | $640.29K |
| EPS Diluted | -$0.07 | $0.05 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Inhibitor Therapeutics, Inc. · CIK 1042418 · Engraved from SEC EDGAR
ended Sep 30, 2013 · filed Nov 14, 2013 · 45 d after period end
